Analysis of the expression and genetic alteration of CLDN18 in gastric cancer
Figure 9.Overall survival of GC patients grouped by CLDN18 median cutoff into high and low groups. (A) TCGA-STAD; (B) GSE84437; (C–F) KM-plotter, data from six datasets: GSE14210, GSE15459, GSE22377, GSE29272, GSE52205, GSE62254.